RxDoctor Payments Data

William Maher, DO

Family Medicine · Des Moines, IANPI 1265410450

Payments from drug & device makers

$800in general payments, 2019–2025

Across 56 payments — averaging $14.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$579
  • AbbVie$80
  • Boehringer Ingelheim$35
  • Sunovion Pharmaceuticals Inc.$26
  • Alkermes, Inc.$24
  • Novartis$16
  • plus $40 from 3 others

What the payments were for

  • Food & beverage$800100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$800 in reported general payments places this provider in the 80th percentile of 1,357 family medicine providers in Iowa.

See all family medicine providers in Iowa

Medicare billing

Part B allowed, 2024
$179,142
Medicare patients
281
Services billed
7,622

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin64$87,659
JanuviaSitagliptin Phosphate43$65,315
OzempicSemaglutide56$63,898
EliquisApixaban34$31,060
MounjaroTirzepatide20$20,219
TrulicityDulaglutide12$19,778
LinzessLinaclotide23$17,851
Spiriva RespimatTiotropium Bromide14$11,204
Trelegy ElliptaFluticasone/Umeclidin/Vilanter17$10,477
FarxigaDapagliflozin Propanediol14$9,255
Incruse ElliptaUmeclidinium Bromide14$7,021
MyrbetriqMirabegron11$4,772
Atorvastatin Calcium646$4,199
Levothyroxine Sodium333$3,230
Lantus SolostarInsulin Glargine,hum.Rec.Anlog31$3,162

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance, Spiriva Respimat$35$98,86378 claims
Novo NordiskOzempic$579$63,89856 claims
AbbVieLinzess, Synthroid$80$19,70338 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 1,357 family medicine providers in Iowa.

Other family medicine in Des Moines

See the full list for Iowa

Where these figures come from

Is this you, or does something look wrong? →